newratings.com  Oct 21  Comment 
BRUSSELS (dpa-AFX) - The Swiss stock market got off to a positive start Friday, but quickly ran out of steam and dropped solidly into negative territory. The market was then stuck in a sideways trend for most of the afternoon. The weak performance...
FierceBiotech  Oct 19  Comment 
Novartis invests, partners with Y Combinator grad in lysosomal storage disorders slawrence Wed, 10/19/2016 - 13:14
Benzinga  Oct 19  Comment 
Shares of Cerulean Pharma Inc (NASDAQ: CERU) are up over 50 percent on roughly 19 times its average volumes on Wednesday. News Behind Move The clinical-stage company said in a Businesswire release that it has struck a strategic collaboration...
FierceBiotech  Oct 19  Comment 
Novartis partners with tiny microcap Cerulean as it nabs $20M slawrence Wed, 10/19/2016 - 09:16
FiercePharma  Oct 18  Comment 
Novartis, late to the Advair generics party, urges FDA to block rival copycats chelfand Tue, 10/18/2016 - 10:25
FiercePharma  Oct 12  Comment 
Novartis adds new chemo-topping data to Zykadia marketing arsenal chelfand Wed, 10/12/2016 - 08:58
FiercePharma  Oct 10  Comment 
Novartis sponsors Queen Latifah's mom-inspired heart failure awareness push aliu Mon, 10/10/2016 - 08:13
FierceBiotech  Oct 10  Comment 
Novartis edges closer to market, rival Ibrance with latest PhIII data update badams Mon, 10/10/2016 - 04:00
newratings.com  Oct 9  Comment 
BASEL (dpa-AFX) - Novartis (NVS) announced updated results from Phase II study (ASCEND-3), which demonstrated that anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients taking Zykadia (ceritinib). Results were...


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki